Device / Technology News

RSS

MediciGlobal launches latest version of ADapt patient recruitment system

CROs and Pharmaceutical companies are speeding the process of study launch and accelerating patient recruitment. Such initiatives involve the adoption of new processes, technologies and organisational structure. One such initiative is MediciGlobal's unique and proprietary web-based system called ADapt, focused on launching patient recruitment programmes faster.

24 Sep 2009

NHSSC awards contract to AMS to supply SUI treatment devices in UK

American Medical Systems (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that it has been included as part of a multiple-awardees contract by National Healthcare Services (NHS) Supply Chain (NHSSC) to supply three of its clinically-proven female stress urinary incontinence (SUI) treatment devices through the Normanton distribution centre, United Kingdom.

24 Sep 2009

Oxygen Biotherapeutics submits a patent application for its heart attack treatment device

Oxygen Biotherapeutics, Inc. today announced that the company has submitted a patent application for a new invention that uses Oxycyte(R) perfluorocarbon to deliver oxygen as a first aid treatment for victims of heart attacks and strokes. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.

24 Sep 2009

InteGreat's browser-based EHR application to be implemented at Sun Life Family Health Center

The InteGreat division of MED3OOO Group, Inc. recently entered into an agreement to implement and deploy InteGreat EHR, a browser-based electronic health record (EHR) application, throughout the offices Sun Life Family Health Center operates in Pinal County, Central Arizona.

24 Sep 2009

Axial Biotech's SCOLISCORE AIS Prognostic Test now available in the U.S.

Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.

24 Sep 2009

Direct RNA sequencing performed using Helicos’ True Single Molecule Sequencing technology

Helicos BioSciences Corporation a life science company focused on innovative genetic analysis technologies, today announced the publication of a landmark study in which Helicos’ True Single Molecule Sequencing (tSMS)™ technology was used to directly sequence individual molecules of RNA. The paper appeared yesterday in the on-line edition of Nature and will appear in an upcoming 2009 print issue of Nature.

24 Sep 2009

U.S. Department of Energy's Office of Science to host symposium on accelerators

On Monday, October 26, the U.S. Department of Energy's Office of Science will host a Symposium on Accelerators for America's Future in Washington, DC.

24 Sep 2009

AFC announces the successful installation of three Hastelloy LLC in series

AMPAC Fine Chemicals (AFC), a subsidiary of American Pacific Corporation (Nasdaq: APFC), announced today the successful installation, qualification and validation in a cGMP manufacturing environment of a continuous extraction process consisting of three Hastelloy(TM) Liquid-Liquid Centrifuges (LLC) in series.

24 Sep 2009

Customized prosthesis from Custom-fit

Custom-fit is a European funded project, coordinated by Delcam, which has developed a new and cost effective way to manufacture fully customised products, individually designed starting from body geometries and putting together rapid manufacturing, information technologies and material science.

24 Sep 2009

Unibased Systems Architecture selected as contracted supplier by Amerinet

Unibased Systems Architecture, Inc. (Unibased) has been selected by Amerinet, Inc. as a contracted supplier of process improvement and workflow enhancement solutions with ForSite2020, a totally integrated comprehensive suite of enterprise solutions for pre-visit access management and business process improvement, dedicated to reducing costs and improving quality of care.

24 Sep 2009

Stereotaxis showcases its remote magnetic navigation technology at TCT symposium

Stereotaxis, Inc. is showcasing the value of its technologies for interventional procedures at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in San Francisco this week.

24 Sep 2009

Everolimus-eluting stent efficient in treating native coronary artery lesions

Late-breaking data from SPIRIT IV, a large-scale multi-center study of nearly 4,000 patients in the U.S., shows that an everolimus-eluting stent demonstrated enhanced safety and efficacy in the treatment of de novo native coronary artery lesions when compared to a paclitaxel-eluting stent, and showed that "low late loss" may be achieved with drug-eluting stents without sacrificing safety.

24 Sep 2009

District court of Frankfurt, Germany rules in favour of Occlutech

Occlutech GmbH, the leading European developer of products for septal closure, today announced that the district court of Frankfurt, Germany reversed an earlier court injunction obtained by AGA Medical against Occlutech's sales and marketing activities relating to the newly launched Figulla Flex ranges of ASD and PFO occluders.

24 Sep 2009

Mayo Clinic Health Manager users have access to blood pressure trackers

As part of Mayo Clinic and Microsoft Corp.'s shared vision to help families take better care of their health, the two companies have made enhancements to Mayo Clinic Health Manager, a free online application designed to help people organize and better manage their health. People with conditions such as hypertension and high cholesterol will now have access to a variety of trackers and up-to-date information to help keep their conditions under control.

24 Sep 2009

Clinical trial comparing Boston Scientific's coronary stent systems

Boston Scientific Corporation today welcomed one-year data from the SPIRIT IV clinical trial comparing the XIENCE V((R)) (PROMUS((R))) Everolimus-Eluting Coronary Stent System to the TAXUS((R)) Express2(TM) Paclitaxel-Eluting Coronary Stent System. The results support the benefits of paclitaxel-eluting stents in diabetic patients. The trial enrolled 3,690 patients, including 1,140 diabetics, the largest diabetic subset ever studied in a drug-eluting stent clinical trial.

24 Sep 2009

Growth in demand for Noveko International's antimicrobial products

Noveko International Inc. ("the Company") is pleased to announce that the value of its firm orders for its Noveko(TM) antimicrobial face masks and respirators and AZURO(TM) hand sanitizers, for the period beginning July 1st, 2009, currently totals approximately $18 million, i.e. $12 million for face masks and respirators and $6 million for sanitizers. This significant number of orders reflects the sharp increase in demand for the Company's antimicrobial products. The orders come mainly from various distributors, notably Eval Consulting, BLD Distribution L.L.C., Aerosys Technologies and Medi-Select.

24 Sep 2009

Researchers to discuss ways to develop mathematical control theory methods for ABMs at NIMBioS workshop

Agent-based models (ABMs) are powerful computer-simulation modeling techniques that used increasingly to understand a broad range of biological phenomena, such as tumor growth, the immune system, and the spread of infectious diseases through a population.

24 Sep 2009

Global Med to market the Spanish verIDhemos transfusion safety system

Global Med Technologies(R), Inc. an international healthcare information technology company, today announced that it has signed a binding letter of intent with verIDentia SL of Macanet De La Selva, Girona, Spain for its verIDhemos transfusion safety system. Terms of the agreement were not disclosed.

24 Sep 2009

Pre-clinical data demonstrates advantages of Combo Stent

OrbusNeich announced today that pre-clinical data involving porcine coronary models demonstrate that the company's Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher(R) sirolimus eluting stent and the XIENCE(TM) V everolimus eluting stent.

24 Sep 2009

Clinical study results of Novolimus and Myolimum eluting coronary stent systems released

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today positive results from three multicenter first-in-man studies of Novolimus and Myolimus eluting coronary stent systems with durable and bioabsorbable polymers. Findings were presented at the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT 2009) scientific symposium.

24 Sep 2009